Adaptive Biotechnologies (ADPT) Balance Sheet

Click line-items for a historical chart and %

Current assets:
Cash and cash equivalents	31.71M
Marketable securities	96.19M
Restricted cash
Prepaid expenses and other current assets	3.94M
Assets held for sale
Total current assets	187.32M
Other long-term assets	531K
Total Assets	344.82M
Current liabilities:
Accounts payable	2.78M
Accrued and other liabilities	8.46M
3/4% convertiable senior subordinated notes due 2023
Total current liabilities	33.33M
Other long-term liabilities	236K
Deferred income taxes	737K
Total liabilities	76.97M
Commitments and contingencies (Note 8)	0
Shareholders' Equity:
Common stock	14K
Additional paid-in capital	270.52M
Accumulated other comprehensive income, net of taxes	-5.55M
Retained earnings	89.23M
Total shareholders' equity	268.25M
Total Liabilities and Shareholders' Equity	344.82M

Entities mentioned with ADPT